TrialOphthalmology. Retina2021

Cost-Utility of Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion.

James Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.